“…The biologic activity ofpurified bFGF toward keratinocytes in vitro was only recently reported (31 (12,34,35). In this work, EGF promoted reepithelialization with a single application and thus this model may be a highly appropriate model to further analyze EGF as a wound healing agent.…”
The roles of polypeptide growth factors in promoting wound healing and in directing the specificity and sequence of responses of different tissues in wounds are little understood. We investigated the influence of four growth factors on the rates of healing of a novel full thickness dermal ulcer placed on an avascular base in the rabbit ear. The wound model precludes significant wound contraction and requires new granulation tissue and epithelial cells for healing to originate centripetally. 5 ;Ig pmol/mm2) of platelet-derived growth factor-B chain (PDGF-BB), basic fibroblast growth factor (bFGF), and epidermal growth factor (EGF) applied locally at the time of wounding resulted in a twofold increase in complete reepithelialization of treated wounds (PDGF-BB, P = 0.02 chi square analysis; bFGF, P = 0.04; EGF, P = 0.05); transforming growth factor (TGF)-f}1 significantly inhibited reepithelialization (P = 0.05).Both PDGF-BB and TGF-,f1 uniquely increased the depth and area of new granulation tissue (P < 0.005), the influx of fibroblasts, and the deposition of new matrix into wounds. Explants from 7-d old PDGF-BB-treated wounds remained metabolically far more active than controls, incorporating 473% more [3Hlthymidine into DNA (P = 0.05) and significantly more I3Hlleucine and I3Hlproline into collagenase-sensitive protein (P = 0.04). The results establish that polypeptide growth factors have significant and selective positive influences on healing of full thickness ulcers in the rabbit. (J. Clin. Invest. 1991.
“…The biologic activity ofpurified bFGF toward keratinocytes in vitro was only recently reported (31 (12,34,35). In this work, EGF promoted reepithelialization with a single application and thus this model may be a highly appropriate model to further analyze EGF as a wound healing agent.…”
The roles of polypeptide growth factors in promoting wound healing and in directing the specificity and sequence of responses of different tissues in wounds are little understood. We investigated the influence of four growth factors on the rates of healing of a novel full thickness dermal ulcer placed on an avascular base in the rabbit ear. The wound model precludes significant wound contraction and requires new granulation tissue and epithelial cells for healing to originate centripetally. 5 ;Ig pmol/mm2) of platelet-derived growth factor-B chain (PDGF-BB), basic fibroblast growth factor (bFGF), and epidermal growth factor (EGF) applied locally at the time of wounding resulted in a twofold increase in complete reepithelialization of treated wounds (PDGF-BB, P = 0.02 chi square analysis; bFGF, P = 0.04; EGF, P = 0.05); transforming growth factor (TGF)-f}1 significantly inhibited reepithelialization (P = 0.05).Both PDGF-BB and TGF-,f1 uniquely increased the depth and area of new granulation tissue (P < 0.005), the influx of fibroblasts, and the deposition of new matrix into wounds. Explants from 7-d old PDGF-BB-treated wounds remained metabolically far more active than controls, incorporating 473% more [3Hlthymidine into DNA (P = 0.05) and significantly more I3Hlleucine and I3Hlproline into collagenase-sensitive protein (P = 0.04). The results establish that polypeptide growth factors have significant and selective positive influences on healing of full thickness ulcers in the rabbit. (J. Clin. Invest. 1991.
“…Although the use of EGF in human impaired wound healing by Falanga et al (1992) showed a modest improvement in wound healing times and rate of epithelialization, the results were not statistically significant. Some other reports also suggested that the efficacy of EGF in chronic wounds is limited (Franklin & Lynch 1979;Brown et al, 1989). Therefore, no conclusions about the efficacy of EGF for chronic wounds can be made at present.…”
Section: Epidermal Growth Factor (Egf)mentioning
confidence: 98%
“…Enhanced wound healing has been noted in dermal wounds treated with topical or subcutaneous EGF (Starkey et al, 1975). Franklin & Lynch (1979) recorded quicker epithelial regeneration and less scar contracture in EGF-treated wounds in rabbits. With the introduction of recombinant human EGF in the 1980s, the range of studies increased to include burn wounds and chronic ulcers (Brown et al, 1989;Falanga et al, 1992).…”
“…In addition, EGF not only promotes formation of granulation tissue but also stimulates fibroblast motility that induces cell-cell adhesive properties consistent with an epithelial phenotype, thereby enhancing the early wound closure [5,10]. Topical application of ointment with EGF to full-thickness wounds made in rabbit's ears enabled the early repair of the wound [8]. Further, application of a silver sulfadiazine cream with EGF has brought significant acceleration of epidermal regeneration at the sites of grafted skins in 12 human patients [2].…”
ABSTRACT. We examined in vivo efficiency of a gelatin film sheet with epidermal growth factor (EGF) for a novel therapeutic device for cutaneous wound repair. NIH3T3 fibroblasts and PAM212 keratinocytes proliferated when the cells were incubated with the homogenate of EGF containing gelatin sheets, indicating that the gelatin sheet retained biologic activity of EGF in the process of sheet formation. To evaluate therapeutic effects, the EGF containing gelatin sheets or control sheets were applied onto partial-thickness skin wounds made on dorsa of hairless dogs. Wound closure in wounds treated with EGF containing gelatin sheets was accelerated when compared to that of wounds treated with control sheets, exhibiting earlier reepithelialization of the epidermis and highly regulated repair of extracellular matrix in the dermis. Therefore, we concluded that the gelatin film is a useful material to keep EGF stable and the EGF containing sheet has the ability to become an efficient therapeutic agent for superficial or deep partial-thickness wounds in the skin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.